Big Pharma’s getting really interested in really tiny RNA.
GlaxoSmithKline has inked a deal with a company called Regulus, a joint venture of Alnylam and Isis that’s doing research in a budding field around something called microRNA. The crux of it, discussed in more detail in this post, is that microRNAs are itty bitty strands of [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment